WRQ-20648-45797
2 vaccinations
2 coded responses
18 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 481 / MI
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-24
Registered in v-safe
-
2021-02-24
Dose 1 — Pfizer-BioNTech
- 2021-02-24
- 2021-02-25
- 2021-02-26
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-10
-
2021-03-17
Dose 2 — Pfizer-BioNTech
- 2021-03-24
- 2021-03-31
- 2021-04-07
- 2021-04-16
-
2021-04-23
Survey response — day 35, dose 2MedDRA: Headache — Feeling: Good · Be unable to do your normal daily activitiesFree text: HeadacheMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
- 2021-06-16
-
2021-09-15
Survey response — 6 months, dose 2MedDRA: Cough, Dehydration, Paranasal sinus discomfort, Paranasal sinus hypersecretion, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visitFree text: Congestion, sinus pressure/drainage, cough, runny nose, dehydrationMedDRA releases: 2024-11 · check-in free text available
-
2021-09-15
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2021-09-20
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2022-03-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Pfizer-BioNTech | |
| 2 | 2021-03-17 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-09-15 | Successful 2021-09-20 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 7 — day 35, dose 2
Symptoms: Headache
Release 9 — 6 months, dose 2
Symptoms: Congestion, sinus pressure/drainage, cough, runny nose, dehydration
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Dehydration | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Paranasal sinus discomfort | · | · | ✓ |
| SD | Paranasal sinus hypersecretion | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release